262 related articles for article (PubMed ID: 24389438)
81. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
82. Surveillance Implications of Recurrence Patterns in Early Node-Negative Esophageal Adenocarcinoma.
Nobel TB; Livschitz J; Xing XX; Barbetta A; Hsu M; Tan KS; Sihag S; Jones DR; Molena D
Ann Thorac Surg; 2019 Dec; 108(6):1640-1647. PubMed ID: 31323215
[TBL] [Abstract][Full Text] [Related]
83. Patterns of surveillance following curative intent therapy for gastroesophageal cancer.
Peixoto RD; Lim HJ; Kim H; Abdullah A; Cheung WY
J Gastrointest Cancer; 2014 Sep; 45(3):325-33. PubMed ID: 24756830
[TBL] [Abstract][Full Text] [Related]
84. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.
Bates BA; Detterbeck FC; Bernard SA; Qaqish BF; Tepper JE
J Clin Oncol; 1996 Jan; 14(1):156-63. PubMed ID: 8558191
[TBL] [Abstract][Full Text] [Related]
85. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
86. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
[TBL] [Abstract][Full Text] [Related]
87. Analysis of the causes of failure after radical surgery in patients with
Shen WB; Gao HM; Zhu SC; Li YM; Li SG; Xu JR
World J Surg Oncol; 2017 Oct; 15(1):192. PubMed ID: 29070049
[TBL] [Abstract][Full Text] [Related]
88. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.
Wang BY; Liu CY; Lin CH; Hsu PK; Hsu WH; Wu YC; Cheng CY
Ann Surg Oncol; 2012 Jul; 19(7):2149-58. PubMed ID: 22407313
[TBL] [Abstract][Full Text] [Related]
89. Total thoracic esophagectomy for esophageal cancer.
Anikin VA; McManus KG; Graham AN; McGuigan JA
J Am Coll Surg; 1997 Dec; 185(6):525-9. PubMed ID: 9404874
[TBL] [Abstract][Full Text] [Related]
90. Postoperative Adjuvant Therapy Improves Survival in Pathologic Nonresponders After Neoadjuvant Chemoradiation for Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis.
Hsu HY; Chao YK; Hsieh CH; Wen YW; Chang HK; Tseng CK; Liu YH
Ann Thorac Surg; 2016 Nov; 102(5):1687-1693. PubMed ID: 27457831
[TBL] [Abstract][Full Text] [Related]
91. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
92. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
[TBL] [Abstract][Full Text] [Related]
93. Unique Considerations for Females Undergoing Esophagectomy.
Nobel TB; Livschitz J; Eljalby M; Janjigian YY; Bains MS; Adusumilli PS; Jones DR; Molena D
Ann Surg; 2020 Jul; 272(1):113-117. PubMed ID: 30672802
[TBL] [Abstract][Full Text] [Related]
94. [Surgical therapy of esophageal cancer--early results].
Hildebrandt J; Nürnberger H; Lehner J; Löhlein D
Med Klin (Munich); 1994 Sep; 89(9):459-63. PubMed ID: 7968879
[TBL] [Abstract][Full Text] [Related]
95. Disease-free interval length correlates to prognosis of patients who underwent metastasectomy for esophageal lung metastases.
Shiono S; Kawamura M; Sato T; Nakagawa K; Nakajima J; Yoshino I; Ikeda N; Horio H; Akiyama H; Kobayashi K;
J Thorac Oncol; 2008 Sep; 3(9):1046-9. PubMed ID: 18758309
[TBL] [Abstract][Full Text] [Related]
96. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
97. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP
Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327
[TBL] [Abstract][Full Text] [Related]
98. Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer.
Lou F; Sima CS; Rusch VW; Jones DR; Huang J
Ann Thorac Surg; 2014 Nov; 98(5):1755-60; discussion 1760-1. PubMed ID: 25110337
[TBL] [Abstract][Full Text] [Related]
99. Defining low-risk lesions in early-stage esophageal adenocarcinoma.
Sihag S; De La Torre S; Hsu M; Nobel T; Tan KS; Gerdes H; Shah P; Bains M; Jones DR; Molena D
J Thorac Cardiovasc Surg; 2021 Oct; 162(4):1272-1279. PubMed ID: 33334599
[TBL] [Abstract][Full Text] [Related]
100. Comparative study on recurrence pattern and treatment method after radical esophagectomy for esophageal cancer.
Sohda M; Yoshida T; Nakazawa N; Ubukata Y; Kuriyama K; Hara K; Sakai M; Sano A; Yokobori T; Ogawa H; Shirabe K; Saeki H
J Med Invest; 2021; 68(1.2):129-135. PubMed ID: 33994457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
